Advanced Science, 2022 · DOI: 10.1002/advs.202105586 · Published: March 6, 2022
Electroconductive hydrogels are promising for spinal cord injury (SCI) repair due to their similarity to neural tissue. However, they can worsen inflammation. Bone marrow stem cell-derived exosomes (BMSC-exosomes) offer immunomodulatory and regenerative effects. The study develops neural tissue-like electroconductive hydrogels loaded with BMSC-exosomes for SCI treatment. These hydrogels modulate microglial polarization, enhance neural stem cell differentiation into neurons and oligodendrocytes, and increase axon outgrowth. In a mouse SCI model, the combined hydrogels significantly reduced inflammation, enhanced stem cell recruitment, and promoted nerve regeneration, leading to functional recovery. This suggests a promising therapeutic strategy for SCI repair.
The combination of electroconductive hydrogels and BMSC-exosomes represents a promising therapeutic approach for spinal cord injury (SCI) treatment.
The GMPE hydrogel can modulate M1/M2 polarization from an M1- to M2-dominant phenotype via the NF-kB pathway, reducing adverse immune effects after SCI.
The GMPE hydrogel enhances oligodendrocyte differentiation and myelin-associated axonal regeneration, promoting locomotor recovery after SCI.